Äèñêóññèîííûé Êëóá Ðóññêîãî Ìåäèöèíñêîãî Ñåðâåðà

Âåðíóòüñÿ   Äèñêóññèîííûé Êëóá Ðóññêîãî Ìåäèöèíñêîãî Ñåðâåðà > Ôîðóìû âðà÷åáíûõ êîíñóëüòàöèé > Ïåäèàòðèÿ

Ïåäèàòðèÿ Ôîðóìû: Âàêöèíîïðîôèëàêòèêà, Ôîðóì äëÿ âðà÷åé ïåäèàòðîâ, ×àñòî çàäàâàåìûå âîïðîñû, Ïñèõîìîòîðíîå è ðå÷åâîå ðàçâèòèå äåòåé, Äåòñêî-ðîäèòåëüñêèå îòíîøåíèÿ

Îòâåò
 
Îïöèè òåìû Ïîèñê â ýòîé òåìå Îïöèè ïðîñìîòðà
  #1  
Ñòàðûé 26.12.2021, 16:00
jrh jrh âíå ôîðóìà
Ó÷àñòíèê ôîðóìà
 
Ðåãèñòðàöèÿ: 18.04.2012
Ãîðîä: Moscow
Ñîîáùåíèé: 104
Ñêàçàë(à) ñïàñèáî: 29
Ïîáëàãîäàðèëè 2 ðàç(à) çà 2 ñîîáùåíèé
jrh *
Íóæíî ëå÷èòü ùåëî÷íóþ ôîñôàòàçó?

Çäðàâñòâóéòå. Ïîñîâåòóéòå, ïîæàëóéñòà, êàê èíòåðïðåòèðîâàòü è ÷òî äåëàòü ñî ñëó÷àéíî îáíàðóæåííûì ïîâûøåíèåì ùåëî÷íîé ôîñôàòàçû ó ìàëü÷èêà 12 ëåò.

Ñåé÷àñ áåç æàëîá, èíîãäà íåîáúÿñíèìàÿ áîëü â êîëåíå, âåñíîé ïîëëèíîç íà áåðåçó (+ÀÑÈÒ). Çà ïîñëåäíåå âðåìÿ òðè ðàçíûõ (è ñ ðàçíûìè ðåôåðåíñíûìè èíòåðâàëàìè) ðåçóëüòàòà èññëåäîâàíèÿ íà ùåëî÷íóþ ôîñôàòàçó:
Êîä:
24.08.2021    725 [108-702] ÅÄ/ë
11.11.2021    328  [42-362] ÅÄ/ë
10.12.2021    401  [42-362] ÅÄ/ë
×òî ýòî çà ðàçíûå ÅÄèíèöû è íóæíî ëè ïðåäïðèíèìàòü êàêèå-òî äåéñòâèÿ? Îáðàòèòü íà ÷òî-òî âíèìàíèå â äàëüíåéøåì? Íà âñÿêèé ñëó÷àé, ïðèëàãàþòñÿ ÎÀÊ è îñòàëüíàÿ áèîõèìèÿ. Çàðàíåå áîëüøîå ñïàñèáî!!!
Ìèíèàòþðû
Íàæìèòå íà èçîáðàæåíèå äëÿ óâåëè÷åíèÿ
Íàçâàíèå: biochem.2021-11-11.png
Ïðîñìîòðîâ: 11
Ðàçìåð:	96.1 Êá
ID:	228630  Íàæìèòå íà èçîáðàæåíèå äëÿ óâåëè÷åíèÿ
Íàçâàíèå: biochem.2021-12-10.png
Ïðîñìîòðîâ: 9
Ðàçìåð:	76.2 Êá
ID:	228631  Íàæìèòå íà èçîáðàæåíèå äëÿ óâåëè÷åíèÿ
Íàçâàíèå: biochem.2021-08-24.png
Ïðîñìîòðîâ: 66
Ðàçìåð:	90.9 Êá
ID:	228629  Íàæìèòå íà èçîáðàæåíèå äëÿ óâåëè÷åíèÿ
Íàçâàíèå: fe.2021-12-10.png
Ïðîñìîòðîâ: 9
Ðàçìåð:	31.8 Êá
ID:	228632  Íàæìèòå íà èçîáðàæåíèå äëÿ óâåëè÷åíèÿ
Íàçâàíèå: blood-count.2021-12-10.png
Ïðîñìîòðîâ: 11
Ðàçìåð:	191.3 Êá
ID:	228633  

Îòâåòèòü ñ öèòèðîâàíèåì
  #2  
Ñòàðûé 27.12.2021, 11:21
Àâàòàð äëÿ eduardshraibman
eduardshraibman eduardshraibman âíå ôîðóìà
ÂÐÀ×
      
 
Ðåãèñòðàöèÿ: 20.10.2010
Ãîðîä: hadera
Ñîîáùåíèé: 17,971
Ñêàçàë(à) ñïàñèáî: 15
Ïîáëàãîäàðèëè 9,370 ðàç(à) çà 8,944 ñîîáùåíèé
eduardshraibman ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåeduardshraibman ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåeduardshraibman ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåeduardshraibman ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåeduardshraibman ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåeduardshraibman ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåeduardshraibman ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåeduardshraibman ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåeduardshraibman ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåeduardshraibman ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåeduardshraibman ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìå
óâåëè÷åíèå íåçíà÷èòåëüíîå.Ó ðàñòóùèõ ìàëü÷èêîâ ùåëî÷íàÿ ôîñôàòàçà âûøå , ÷åì ó âçðîñëûõ.Ïðè îòñóòñâèè æàëîá, íàõîäîê ïðè îñìîòðå è äðóãèõ èçìåíåíèé â àíàëèçàõ êðîâè íèêàêèå äåéñòâèÿ ïðåäïðèíèìàòü íå íàäî.Ìîæåò ñòîèò ïîäàâàòü ïðîôèëàêòè÷åñêóþ äîçó âèò.Ä
Îòâåòèòü ñ öèòèðîâàíèåì
  #3  
Ñòàðûé 27.12.2021, 15:18
jrh jrh âíå ôîðóìà
Ó÷àñòíèê ôîðóìà
 
Ðåãèñòðàöèÿ: 18.04.2012
Ãîðîä: Moscow
Ñîîáùåíèé: 104
Ñêàçàë(à) ñïàñèáî: 29
Ïîáëàãîäàðèëè 2 ðàç(à) çà 2 ñîîáùåíèé
jrh *
Ñïàñèáî áîëüøîå çà îòâåò!

Öèòàòà:
Ñîîáùåíèå îò eduardshraibman Ïîñìîòðåòü ñîîáùåíèå
óâåëè÷åíèå íåçíà÷èòåëüíîå.Ó ðàñòóùèõ ìàëü÷èêîâ ùåëî÷íàÿ ôîñôàòàçà âûøå , ÷åì ó âçðîñëûõ
Ìàëü÷èê (ïîêà?) íå î÷åíü áûñòðî ðàñòóùèé - 157ñì (åãî ñåñòðà 14 ëåò óæå 180ñì). ß íàäåþñü, ÷òî íîðìû â áëàíêå èç äåòñêîé ïîëèêëèíèêè óêàçàíû äëÿ äåòåé, íî íå çíàþ, êàê èõ ïðîâåðèòü ñ àáñòðàêòíûìè åäèíèöàìè.

Öèòàòà:
Ïðè îòñóòñâèè æàëîá, íàõîäîê ïðè îñìîòðå è äðóãèõ èçìåíåíèé â àíàëèçàõ êðîâè íèêàêèå äåéñòâèÿ ïðåäïðèíèìàòü íå íàäî.
Ó ðåáåíêà íåò àêòèâíûõ æàëîá. Èíîãäà áûâàåò óòðåííÿÿ áîëü â ãîðëå, ïðîõîäÿùàÿ ê ñåðåäèíå äíÿ, â ñâÿçè ñ êîòîðîé ðåêîìåíäîâàíî (óæå äàâíî) èñêëþ÷èòü ÃÝÐÁ, íî î÷åíü íå õî÷åòñÿ äåëàòü ãàñòðîñêîïèþ. Äðóãèå îòêëîíåíèÿ â êðîâè òîæå åñòü, íî ÿ áîëüøå îòðåàãèðîâàë íà ÙÔ. Íà îñìîòðå ïåäèàòð ïðåòåíçèé ê ðåáåíêó íå èìåë. Ìîæåò áûòü ÿ ñàì äîëæåí âíèìàòåëüíî ïîñìîòðåòü íà ÷òî-òî?

Âîò åùå ïîñëåäíÿÿ ÝÊÃ
Êîä:
Îïèñàíèå: ×ÑÑ=55-69 â ìèíóòó PQ=0,12, QRS=0,08,
QT=0,38, QTc=0,36-0,41 ðèòì ñèíóñîâûé.
Çàêëþ÷åíèå: Âûðàæåííàÿ  ñèíóñîâàÿ áðàäèêàðäèÿ, ëåãêàÿ àðèòìèÿ.
Âåðòèêàëüíàÿ ÝÎÑ. Ñèíäðîì ðàííåé ðåïîëÿðèçàöèè æåëóäî÷êîâ.
ÝÊÃ â ïðåäåëàõ âîçðàñòíîé íîðìû.
Öèòàòà:
Ìîæåò ñòîèò ïîäàâàòü ïðîôèëàêòè÷åñêóþ äîçó âèò.Ä
Ñïàñèáî! Îò 7 êàïåëü ÄýÒðèÔåðîëà â íåäåëþ (500ÌÅ/ñóòêè) õóæå íå áóäåò (çèìà â Ìîñêâå)?
Îòâåòèòü ñ öèòèðîâàíèåì
  #4  
Ñòàðûé 28.12.2021, 01:42
Àâàòàð äëÿ eduardshraibman
eduardshraibman eduardshraibman âíå ôîðóìà
ÂÐÀ×
      
 
Ðåãèñòðàöèÿ: 20.10.2010
Ãîðîä: hadera
Ñîîáùåíèé: 17,971
Ñêàçàë(à) ñïàñèáî: 15
Ïîáëàãîäàðèëè 9,370 ðàç(à) çà 8,944 ñîîáùåíèé
eduardshraibman ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåeduardshraibman ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåeduardshraibman ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåeduardshraibman ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåeduardshraibman ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåeduardshraibman ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåeduardshraibman ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåeduardshraibman ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåeduardshraibman ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåeduardshraibman ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåeduardshraibman ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìå
Îò âèò Äý (500ÌÅ/ñóòêè) õóæå íå áóäåò òî÷íî
Îòâåòèòü ñ öèòèðîâàíèåì
  #5  
Ñòàðûé 30.12.2021, 20:51
jrh jrh âíå ôîðóìà
Ó÷àñòíèê ôîðóìà
 
Ðåãèñòðàöèÿ: 18.04.2012
Ãîðîä: Moscow
Ñîîáùåíèé: 104
Ñêàçàë(à) ñïàñèáî: 29
Ïîáëàãîäàðèëè 2 ðàç(à) çà 2 ñîîáùåíèé
jrh *
Ñïàñèáî! Ñ íàñòóïàþùèì íîâûì ãîäîì!
Îòâåòèòü ñ öèòèðîâàíèåì
  #6  
Ñòàðûé 30.12.2021, 21:58
Àâàòàð äëÿ Dr.Vad
Dr.Vad Dr.Vad âíå ôîðóìà
Ìîäåðàòîð ôîðóìà ïî ãåìàòîëîãèè
      
 
Ðåãèñòðàöèÿ: 16.01.2003
Ãîðîä: Õüþñòîí, Òåõàñ
Ñîîáùåíèé: 80,936
Ïîáëàãîäàðèëè 33,484 ðàç(à) çà 31,822 ñîîáùåíèé
Dr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìå
áûñòðî-ðàñòóøèå äåòè ñ ðîñòîì áîëåå 180 íå äîñòèãíó 18 ëåò ïëþñ íåâûñîêèé âåñ ïëþñ îäèí èç ðîäèòåëåé òàêîé æåæ = ìîæåò áûòü ðèñê Ìàðôàíà â ñåìüå èëè äð. çàáîëåâàíèé ñîåä. òêàíè, ïðîâåðüòå ñèìïòîìû ïî êàëüêóëÿòîðó [Ññûëêè äîñòóïíû òîëüêî çàðåãèñòðèðîâàííûì ïîëüçîâàòåëÿì ]
__________________
Èñêðåííå,
Âàäèì Âàëåðüåâè÷.
Îòâåòèòü ñ öèòèðîâàíèåì
  #7  
Ñòàðûé 31.12.2021, 14:22
jrh jrh âíå ôîðóìà
Ó÷àñòíèê ôîðóìà
 
Ðåãèñòðàöèÿ: 18.04.2012
Ãîðîä: Moscow
Ñîîáùåíèé: 104
Ñêàçàë(à) ñïàñèáî: 29
Ïîáëàãîäàðèëè 2 ðàç(à) çà 2 ñîîáùåíèé
jrh *
Öèòàòà:
Ñîîáùåíèå îò Dr.Vad Ïîñìîòðåòü ñîîáùåíèå
áûñòðî-ðàñòóøèå äåòè ñ ðîñòîì áîëåå 180 íå äîñòèãíó 18 ëåò ïëþñ íåâûñîêèé âåñ ïëþñ îäèí èç ðîäèòåëåé òàêîé æåæ = ìîæåò áûòü ðèñê Ìàðôàíà â ñåìüå èëè äð. çàáîëåâàíèé ñîåä. òêàíè, ïðîâåðüòå ñèìïòîìû ïî êàëüêóëÿòîðó
Ñïàñèáî, ýòî â ñâÿçè ñ âîïðîñîì î ñûíå èëè îáùàÿ (ñåìåéíàÿ) ðåêîìåíäàöèÿ?

Ïîïðîáóþ îòâåòèòü äëÿ ìàëü÷èêà 12 ëåò, ìàññîé 38.7 êã, è ðîñòîì 157ñì (ìàìà 175ñì, ïàïà 183ñì):
LS=80cm, US=77cm, US/LS=0.96
Armspan=151cm
Armspan/height=0.96
  • Thumb sign (íà îäíîé ðóêå) (+)
  • Wrist sign (-)
  • Hindfoot Deformity (-)
  • Plain Flat Foot (+)
  • Scoliosis or Thoracolumbar Kyphosis (M41.1 - Þíîøåñêèé èäèîïàòè÷åñêèé ñêîëèîç (M41.1). ñêîëèîç ãðóäíîãî îòäåëà 1 ñò. Ïîòîì áûëà îòìå÷åíà "ïîëîæèòåëüíàÿ äèíàìèêà" è ïåðåêâàëèôèöèðîâàíî â M53.2 - Ñïèíàëüíàÿ íåñòàáèëüíîñòü. Ïîäòâåðæäåí. Íàðóøåíèå îñè ïîçâîíî÷íèêà.) (+)
  • Three of five facial features (çäåñü ÿ ñîâñåì íå óâåðåí) (-)
    dolichocephaly (-)
    downward slanting palpebral fissures (÷óòü-÷óòü) (+)
    enophthalmos (-)
    retrognathia and malar hypoplasia (ïðîáëåìû ñ ïðèêóñîì åñòü, ñ êîòîðûìè íå î÷åíü óñïåøíî ñïðàâëÿåìñÿ ïðè ïîìîùè ïëàñòèíîê, íàçíà÷åííûõ îðòîäîíòîì) (?)
  • Ïî îñòàëüíûì ïóíêòàì îòðèöàòåëüíî èëè "íåäîîáñëåäîâàíî".
ß íàñ÷èòàë Systemic Score=3, íóæíî åùå ÷òî-òî ñäåëàòü?

Íå çíàþ, âàæíî ëè ýòî, íî âðîæäåííàÿ ñîåä.òêàííàÿ äèñïëàçèÿ ó ýòîãî ðåáåíêà îáñóæäàëàñü ðàíåå.
Îòâåòèòü ñ öèòèðîâàíèåì
  #8  
Ñòàðûé 02.01.2022, 10:53
Àâàòàð äëÿ eduardshraibman
eduardshraibman eduardshraibman âíå ôîðóìà
ÂÐÀ×
      
 
Ðåãèñòðàöèÿ: 20.10.2010
Ãîðîä: hadera
Ñîîáùåíèé: 17,971
Ñêàçàë(à) ñïàñèáî: 15
Ïîáëàãîäàðèëè 9,370 ðàç(à) çà 8,944 ñîîáùåíèé
eduardshraibman ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåeduardshraibman ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåeduardshraibman ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåeduardshraibman ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåeduardshraibman ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåeduardshraibman ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåeduardshraibman ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåeduardshraibman ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåeduardshraibman ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåeduardshraibman ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåeduardshraibman ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìå
Systemic Score=3- íè÷åãî íå íàäî ïðè òàêîì ïîêàçàòåëå
Îòâåòèòü ñ öèòèðîâàíèåì
  #9  
Ñòàðûé 02.01.2022, 19:38
Àâàòàð äëÿ Dr.Vad
Dr.Vad Dr.Vad âíå ôîðóìà
Ìîäåðàòîð ôîðóìà ïî ãåìàòîëîãèè
      
 
Ðåãèñòðàöèÿ: 16.01.2003
Ãîðîä: Õüþñòîí, Òåõàñ
Ñîîáùåíèé: 80,936
Ïîáëàãîäàðèëè 33,484 ðàç(à) çà 31,822 ñîîáùåíèé
Dr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìå
â çàâèñèìîñòè îò òîãî, ÷òî íåäîîáñëåäîâàíî è êàêèå áàëëû ìîãóò áûòü - âîïðîñ îòêðûò
__________________
Èñêðåííå,
Âàäèì Âàëåðüåâè÷.
Îòâåòèòü ñ öèòèðîâàíèåì
  #10  
Ñòàðûé 03.01.2022, 16:47
jrh jrh âíå ôîðóìà
Ó÷àñòíèê ôîðóìà
 
Ðåãèñòðàöèÿ: 18.04.2012
Ãîðîä: Moscow
Ñîîáùåíèé: 104
Ñêàçàë(à) ñïàñèáî: 29
Ïîáëàãîäàðèëè 2 ðàç(à) çà 2 ñîîáùåíèé
jrh *
Èçâèíèòå, ðàñïèøó ïîäðîáíî ïî ïóíêòàì:
  • Wrist AND thumb sign (0/3)
  • Wrist OR thumb sign (1/1)
  • Pectus carinatum deformity (ñóäÿ ïî êàðòèíêàì èç èíòåðíåòîâ íåò) (?/2)
  • pectus excavatum or chest asymmetry (àñèììåòðèÿ, íà ìîé âêóñ, ìåíüøå ÷åì in the general population = ó ìåíÿ ñàìîãî) (?/1)
  • Hindfoot deformity (0/2)
  • Plain flat foot (1/1)
  • Pneumothorax (0/2)
  • Dural ectasia (?/2)
  • Protrusio acetabulae (?/2)
  • Reduced US/LS and increased armspan/height (0/1)
  • Scoliosis or thoracolumbar kyphosis (1/1)
  • Reduced elbow extension (0/1)
  • 3/5 facial features (?/1)
  • Skin striae (0/1)
  • Myopia (1-2 äèîïòðèÿ) (0/1)
  • Mitral valve prolapse (â 2016 ãîäó íå áûëî) (0/1)
Îòâåòèòü ñ öèòèðîâàíèåì
  #11  
Ñòàðûé 03.01.2022, 17:59
Àâàòàð äëÿ Dr.Vad
Dr.Vad Dr.Vad âíå ôîðóìà
Ìîäåðàòîð ôîðóìà ïî ãåìàòîëîãèè
      
 
Ðåãèñòðàöèÿ: 16.01.2003
Ãîðîä: Õüþñòîí, Òåõàñ
Ñîîáùåíèé: 80,936
Ïîáëàãîäàðèëè 33,484 ðàç(à) çà 31,822 ñîîáùåíèé
Dr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìå
ïîõîæå, ÷òî ðèñê íåâåëèê, íî åòî êëàññè÷åñêèé Ìàðôàí, áûâàþò àòèïè÷íûå ôîðìû èëè æå äðóãàÿ ïàòîëîãèÿ ñîåä. òêàíè, äëÿ êîòîðîé ïîêà íåò êàëüêóëÿòîðîâ ðèñêà
__________________
Èñêðåííå,
Âàäèì Âàëåðüåâè÷.
Îòâåòèòü ñ öèòèðîâàíèåì
  #12  
Ñòàðûé 03.01.2022, 18:01
Àâàòàð äëÿ Dr.Vad
Dr.Vad Dr.Vad âíå ôîðóìà
Ìîäåðàòîð ôîðóìà ïî ãåìàòîëîãèè
      
 
Ðåãèñòðàöèÿ: 16.01.2003
Ãîðîä: Õüþñòîí, Òåõàñ
Ñîîáùåíèé: 80,936
Ïîáëàãîäàðèëè 33,484 ðàç(à) çà 31,822 ñîîáùåíèé
Dr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìå
atypical Marfan syndrome (MFS): had some Marfanoid features, did not meet the Ghent criteria for MFS, and/or were FBN1 negative
__________________
Èñêðåííå,
Âàäèì Âàëåðüåâè÷.
Îòâåòèòü ñ öèòèðîâàíèåì
  #13  
Ñòàðûé 03.01.2022, 18:11
Àâàòàð äëÿ Dr.Vad
Dr.Vad Dr.Vad âíå ôîðóìà
Ìîäåðàòîð ôîðóìà ïî ãåìàòîëîãèè
      
 
Ðåãèñòðàöèÿ: 16.01.2003
Ãîðîä: Õüþñòîí, Òåõàñ
Ñîîáùåíèé: 80,936
Ïîáëàãîäàðèëè 33,484 ðàç(à) çà 31,822 ñîîáùåíèé
Dr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìå
äîáàâëþ, ÷òî ìîè ñóæäåíèÿ áûëè äëÿ äåâî÷êè 14 ëåò, ó êîòîðîé ðîñò óæå 180 ñì, íîðìà ðîñòà äëÿ äåâî÷åê â 14-15 ëåò (97 ïåðöåíòèëü) 173 ñì, â áîëüøèíñòâå ñëó÷àåâ - ýòî êîíñòèòóö. âûñîêîðîñëîñòü, íî èíîãäà - ïàòîëîãèÿ:

Tall stature is usually defined as a height beyond 97th percentile or more than 2 SD above the mean height for age and sex in a defined population. Familial tall stature, also known as constitutional tall stature, is the most common cause of tall stature... Tall stature by itself is not a pathological condition, however, there are a number of disorders associated with tall stature. Some genetic disorders and syndromes may be associated with mental retardation and various complications. Therefore, recognition of tall stature and revealing the underlying pathogenic causes and making the diagnosis are important not to miss the serious conditions and to provide adequate medical care and genetic counseling.
Pathological causes for tall statute include endocrine disorders, such as excessive growth hormone secretion, hyperthyroidism, precocious puberty and lipodystrophy, chromosome disorders, such as Trisomy X (47, XXX female), Klinefelter Syndrome (47, XXY), XYY syndrome (47, XYY male) and fragile X syndrome, and syndromes and metabolic disorders, such as Marfan Syndrome, Beckwith-Wiedemann Syndrome, Simpson-Golabi-Behmel Syndrome, Sotos Syndrome and homocystinuria.
---
Minerva Pediatr. 2020 Dec;72(6):472-483.
Tall stature in children and adolescents

Êîììåíòàðèè ê ñîîáùåíèþ:
eduardshraibman îäîáðèë(à):
__________________
Èñêðåííå,
Âàäèì Âàëåðüåâè÷.
Îòâåòèòü ñ öèòèðîâàíèåì
  #14  
Ñòàðûé 05.01.2022, 13:19
jrh jrh âíå ôîðóìà
Ó÷àñòíèê ôîðóìà
 
Ðåãèñòðàöèÿ: 18.04.2012
Ãîðîä: Moscow
Ñîîáùåíèé: 104
Ñêàçàë(à) ñïàñèáî: 29
Ïîáëàãîäàðèëè 2 ðàç(à) çà 2 ñîîáùåíèé
jrh *
Öèòàòà:
Ñîîáùåíèå îò Dr.Vad Ïîñìîòðåòü ñîîáùåíèå
äîáàâëþ, ÷òî ìîè ñóæäåíèÿ áûëè äëÿ äåâî÷êè 14 ëåò
Âàäèì Âàëåðüåâè÷, íàâåðíîå, ÿ òîãäà ëó÷øå îòêðîþ îòäåëüíóþ òåìó ïðî äî÷êó?

Ïî ïîâîäó ìàëü÷èêà 12 ëåò, íà âñÿêèé ñëó÷àé, ÿ ïðàâèëüíî ïîíÿë, ÷òî:
  1. âèòàìèí D 500 I.U./d?
  2. íà 5 ìåñÿöåâ (äî ëåòà)?
  3. æåëåçî íå äàåì?
  4. ïîâòîðèòü ÷åðåç êàêîå-òî âðåìÿ ÙÔ?
  5. ðåãóëÿðíî (íà ñêîëüêî ÷àñòî?) èçìåðÿòü äàâëåíèå? Êàêèå çíà÷åíèÿ ñ÷èòàòü ïðèåìëåìûìè?
  6. ðåãóëÿðíî (íà ñêîëüêî ÷àñòî?) ïîâòîðÿòü ÓÇÈ ñåðäöà?
  7. ÷òî-òî äðóãîå?

Åùå ðàç áîëüøîå ñïàñèáî!
Îòâåòèòü ñ öèòèðîâàíèåì
  #15  
Ñòàðûé 03.01.2022, 18:20
Àâàòàð äëÿ Dr.Vad
Dr.Vad Dr.Vad âíå ôîðóìà
Ìîäåðàòîð ôîðóìà ïî ãåìàòîëîãèè
      
 
Ðåãèñòðàöèÿ: 16.01.2003
Ãîðîä: Õüþñòîí, Òåõàñ
Ñîîáùåíèé: 80,936
Ïîáëàãîäàðèëè 33,484 ðàç(à) çà 31,822 ñîîáùåíèé
Dr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìå
êàê ïðèìåð èç ãîëë. ñòàòüè î 19-òè ïîäðîñòêàõ ñ Ìàðôàíîì: ó âñåõ ïîäòâåðæäåííûé äèàãíîç ãåíåòè÷åñêè, ÍÎ òîëüêî ó ïîëîâèíû êàëüêóëÿöèÿ ðèñêà ïîêàçàëà 7 èëè áîëåå áàëëîâ

Gender (male/female) = 12/7
Age (range) (years) = 14.5 (12–17)
Confirmed pathogenic FBN1 variant = 19
Systemic Ghent score ≥ 7 = 10
__________________
Èñêðåííå,
Âàäèì Âàëåðüåâè÷.
Îòâåòèòü ñ öèòèðîâàíèåì
Îòâåò



Âàøè ïðàâà â ðàçäåëå
Âû íå ìîæåòå ñîçäàâàòü òåìû
Âû íå ìîæåòå îòâå÷àòü íà ñîîáùåíèÿ
Âû íå ìîæåòå ïðèêðåïëÿòü ôàéëû
Âû íå ìîæåòå ðåäàêòèðîâàòü ñîîáùåíèÿ

BB êîäû Âêë.
Ñìàéëû Âêë.
[IMG] êîä Âêë.
HTML êîä Âûêë.



×àñîâîé ïîÿñ GMT +3, âðåìÿ: 02:32.




Ðàáîòàåò íà vBulletin® âåðñèÿ 3.
Copyright ©2000 - 2024, Jelsoft Enterprises Ltd.